Artificial Intelligence Reshaping the Cell and Gene Therapy Manufacturing Landscape, New BCC Research Report Finds

Wednesday, March 18, 2026 · bcc research llc

AI Briefing

Artificial Intelligence is transforming the cell and gene therapy manufacturing landscape, with corporate AI investment reaching $252.3 billion in 2024.
Mergers and acquisitions in the AI sector increased by 12.1% and private investment rose by 44.5%.
The growing use of AI in cell and gene therapy manufacturing is expected to drive innovation and efficiency in the industry.